Chapman University · PharmacologyKaur Lab
Kamaljit Kaur · Orange, California
Research Focus
Dr. Kamaljit Kaur's lab at Chapman University focuses on improving chemotherapy for triple-negative breast cancer (TNBC) using specially designed peptide-drug conjugates. These conjugates are engineered to specifically target cancer cells, aiming to enhance drug effectiveness while minimizing harmful side effects on normal tissues. The lab is working on innovative approaches that could revolutionize cancer treatment and offer better outcomes for patients.
peptide-drug conjugatestriple-negative breast cancerEGFR targetingchemotherapydrug delivery systems
Research Aims
3AIM 01Develop peptide-drug conjugates for targeted delivery to TNBC cells.
AIM 02Investigate the efficacy of linear and cyclic peptides in enhancing chemotherapy.
AIM 03Explore the mechanisms of EGFR-mediated uptake of peptide-drug conjugates in cancer cells.
Skills the Lab Values
solid-phase peptide synthesiscell cultureanimal modelsin vitro assaysbiochemical assays
Output against the department
Publications134bottom 38% of dept.286th of 462
this lab
most publishedleast published
Citations5.5kbottom 40% of dept.275th of 462
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.